Jazz Pharmaceuticals

NASDAQ: JAZZ · Real-Time Price · USD
117.70
1.03 (0.88%)
At close: Aug 15, 2025, 3:59 PM
117.90
0.17%
After-hours: Aug 15, 2025, 07:54 PM EDT

Jazz Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
560.12M 414.83M -224.06M -329.67M
Depreciation & Amortization
660.07M 638.7M 629.47M 552.48M
Stock-Based Compensation
248.04M 226.84M 222M 189.01M
Other Working Capital
n/a -214.04M 160.91M 36.62M
Other Non-Cash Items
212.72M 276.29M 926.92M 345.44M
Deferred Income Tax
-208.33M -260.22M -292.25M 69.2M
Change in Working Capital
-76.72M -204.44M 9.9M -47.95M
Operating Cash Flow
1.4B 1.09B 1.27B 778.51M
Capital Expenditures
-48.07M -23.96M -498.19M -45.53M
Cash Acquisitions
n/a n/a 53M -6.23B
Purchase of Investments
-1.31B -390.1M -61.04M -26.82M
Sales Maturities Of Investments
845M 270M 60M 1.09B
Other Investing Acitivies
-10M -19M n/a n/a
Investing Cash Flow
-508.19M -163.06M -446.23M -5.21B
Debt Repayment
374.77M -31M -582.01M 3.87B
Common Stock Repurchased
-311.43M -269.76M -54K -35.6M
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-42.82M -4.49M -45.44M 99.66M
Financial Cash Flow
20.52M -305.25M -529.49M 3.97B
Net Cash Flow
906.55M 624.83M 290.03M -466.32M
Free Cash Flow
1.35B 1.07B 773.78M 732.98M